Anteris Technologies Global (AVR) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Anteris Technologies Global Corp   (AVR)
 

Anteris Technologies Global Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Anteris Technologies Global Corp inventory turnover ratio, the Anteris Technologies Global Corp 's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 1.64 in the first quarter 2026, a new company high. Average inventory processing period, for the Anteris Technologies Global in Mar 31 2026 quarter, has decreased to 223 days, compare to 225 days, in the Dec 31 2025 quarter.

Within Healthcare sector 239 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form in the fourth quarter 2025, to 1649.

AVR Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Anteris Technologies Global Corp Market Share?

What is Inventory Turnover Ratio?




AVR Inventory Turnover Ratio (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Inventory Growth -66.48 % -70.37 % - - -
Y / Y Cost of Sales Growth -44.93 % -56.46 % -72.23 % -52.56 % -56.24 %
Inventory Turnover Ratio (TTM) 1.64 1.62 1.56 3.04 5.34
AVR's Total Ranking # 1649 # # # #
Average inventory processing period 222 225 234 120 68
Seq. Inventory Growth -19.74 % -65.14 % -2.9 % 23.35 % -29.04 %
Seq. Cost of Sales Growth 25.27 % -26.02 % -16.89 % -28.5 % -0.96 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 109
Healthcare Sector # 240
Overall Market # 1649

Inventory Turnover Ratio Statistics
High Average Low
1.64 1.63 1.62
(Mar 31 2026)   (Dec 31 2025)




Financial Statements
Anteris Technologies Global 's Inventories $ 0 Millions Visit AVR's Balance sheet
Anteris Technologies Global 's Cost of Revenues TTM $ 0 Millions Visit AVR's Income Statement
What are AVR's Sales? Visit AVR's Sales by Segment

Other Inventory Turnover Ratios
Anteris Technologies Global 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
AVR's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for AVR's Competitors
Inventory Turnover Ratio for AVR's Suppliers
Inventory Turnover Ratio for AVR's Customers

You may also want to know
AVR's Sales Growth Rates AVR's Pe Price to earnings ratio AVR's Receivables Turnover Ratio AVR's Stock Quote
AVR's Net Income Growth Rates AVR's Ps Price to Sales ratio AVR's Sales per Employee AVR's Asset Turnover Ratio
AVR's Net Margin AVR's Pb Price to Book ratio AVR's Financial Strength Ratios AVR's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
Zevra Therapeutics Inc   10.44 $ 17.034  Millions$ 2  Millions
Alnylam Pharmaceuticals Inc   10.38 $ 814.503  Millions$ 78  Millions
Nutriband Inc   10.06 $ 1.291  Millions$ 0  Millions
Lantheus Holdings Inc   9.75 $ 610.000  Millions$ 63  Millions
Sotera Health Company  9.58 $ 531.000  Millions$ 55  Millions
Warby Parker Inc   9.23 $ 415.000  Millions$ 45  Millions
National Vision Holdings Inc   8.90 $ 833.415  Millions$ 94  Millions
Myriad Genetics Inc   8.35 $ 248.000  Millions$ 30  Millions
Pulse Biosciences Inc   8.08 $ 0.909  Millions$ 0  Millions
Castle Biosciences Inc   7.97 $ 75.178  Millions$ 9  Millions
Moderna Inc   7.96 $ 1,733.000  Millions$ 218  Millions
Carlsmed Inc   7.95 $ 12.557  Millions$ 2  Millions
Inogen Inc   7.80 $ 195.741  Millions$ 25  Millions
Cardiff Lexington Corporation  7.70 $ 4.159  Millions$ 1  Millions
Novavax inc   7.67 $ 89.620  Millions$ 12  Millions
Prophase Labs Inc   7.64 $ 2.361  Millions$ 0  Millions
Bellevue Life Sciences Acquisition Corp  7.62 $ 1.985  Millions$ 0  Millions
Lifemd Inc   7.60 $ 24.000  Millions$ 3  Millions
Tarsus Pharmaceuticals Inc   7.60 $ 31.627  Millions$ 4  Millions
Charles River Laboratories International inc   7.56 $ 2,346.239  Millions$ 310  Millions
Adaptive Biotechnologies Corporation  7.43 $ 73.088  Millions$ 10  Millions
Puma Biotechnology Inc   7.19 $ 58.025  Millions$ 8  Millions
Fonar Corporation  7.06 $ 19.685  Millions$ 3  Millions
Carlisle Companies Incorporated  6.71 $ 3,206.100  Millions$ 478  Millions
Hims and Hers Health Inc   6.58 $ 670.000  Millions$ 102  Millions
Vanda Pharmaceuticals Inc   6.54 $ 12.682  Millions$ 2  Millions
Twist Bioscience Corporation  6.50 $ 196.251  Millions$ 30  Millions
Phathom Pharmaceuticals Inc   6.48 $ 30.871  Millions$ 5  Millions
Precision Optics Corporation Inc   6.47 $ 24.932  Millions$ 4  Millions
Nuo Therapeutics Inc   6.42 $ 1.331  Millions$ 0  Millions

Date modified: 2026-08-30T15:07:57+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.